Where does Fidia Farmaceutici S.p.A. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Fidia Farmaceutici S.p.A. ranks #6,771 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Fidia Farmaceutici S.p.A. hold?

Fidia Farmaceutici S.p.A. holds 49 US utility patents granted between 2015 and 2025, spanning 21 technology areas.

What is Fidia Farmaceutici S.p.A.'s Innovation Score?

Fidia Farmaceutici S.p.A. has an Innovation Score of 40.2 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Fidia Farmaceutici S.p.A. focus on?

Fidia Farmaceutici S.p.A.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 43 patents, ranking #519 of 7,163 assignees active in that subclass. Grants appear in 21 CPC subclasses total.

Is Fidia Farmaceutici S.p.A.'s patent grant rate increasing or decreasing?

Fidia Farmaceutici S.p.A.'s recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Fidia Farmaceutici S.p.A.'s patents?

Fidia Farmaceutici S.p.A.'s patents average 11.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Fidia Farmaceutici S.p.A. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Fidia Farmaceutici S.p.A.

USPTO PatentsView assignee record - 49 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Fidia ranks #6,771 of 49,997 tracked US assignees by granted-patent volume, with 49 patents across 21 technology areas.

#6,771
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.2/100): 11.6
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6771 · Foreign Corporation #6,771 · 49 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 49 grants
UPPER-Q #6,771/49,997
PHOTO-FINISH Editas Medicine
CPC-FOCUS A61K · 21 areas
INNOV-PAR 40.2/100
CLAIMS-PAR 11.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Editas Medicine, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Fidia’s 40.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.5 pts (33%) Velocity 3.6 pts (9%) Breadth 16.2 pts (40%) Claim depth 7.0 pts (17%)

Qualcomm Incorporated · highest

85
Atop S p A · near

40
Federal-Mogul… · near

40
Fidia Farmaceutici… · this assignee

40
Grace Engineering · near

40
J J Mackay Canada · near

40
3D Lighting… · lowest

7

What this shows Fidia's Innovation Score is 40.2/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Fidia?

Each dot is one of Fidia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fidia’s own 11.6 claims/patent is at or below the 14.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Fidia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Fidia's grants concentrate

Fidia Farmaceutici S.p.A. is a focused PatentsView assignee: 21 CPC subclasses with 87.8% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2017 (8 grants) versus a trough of 2 in 2023. By volume, Fidia sits between Editas Medicine, Inc. and GE Healthcare UK Limited.

Fidia's three-year grant acceleration

Fidia Farmaceutici S.p.A. shows 8 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Editas Medicine

49
Elite Semiconduct…

49
Endress+Hauser Co…

49
Express Imaging S…

49
Fairfield Industr…

49
Friedrich-schille…

49
Future Dial

49
GE Healthcare UK

49
Fidia Farmaceutic… ◀

49

What this shows Fidia holds 49 patents at rank #6,770, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Fidia

By rank, the assignees closest to #6,770 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Fidia's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Fidia, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Fidia ranks #519 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Atop S.p.A. 40 Grace Engineering Corp. 40 J.J. Mackay Canada Limited 40 Federal-Mogul Wiesbaden GmbH 40

Fidia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Fidia Farmaceutici S.p.A. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	8.2%
2016	6	12.2%
2017	8	16.3%
2018	4	8.2%
2019	5	10.2%
2020	5	10.2%
2021	5	10.2%
2022	4	8.2%
2023	2	4.1%
2024	2	4.1%
2025partial year	4	8.2%

Which technologies does Fidia Farmaceutici S.p.A. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 43

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 27

C08B - POLYSACCHARIDES; Derivatives Thereof 20

C12Y - Enzymes 14

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 7

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 6

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 5

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

C08L - Compositions OF Macromolecular Compounds 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

C07K - Peptides 2

C07D - Heterocyclic Compounds 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

B02C - Crushing, Pulverising, OR Disintegrating IN GENERAL; Milling Grain 1

Top 15 of 21 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Fidia Farmaceutici S.p.A.'s patent record in context - here's where to go next.

Fidia Farmaceutici S.p.A.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 87.8% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #6,771 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Fidia Farmaceutici S.p.A. against Editas Medicine, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.